Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
This launch is part of the company's strategy to expand its nutraceutical portfolio
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Subscribe To Our Newsletter & Stay Updated